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The CD28 and CTLA-4 Receptors Associate
with the Serine/Threonine Phosphatase PP2A
CD28 receptor leads to activation of the Src family tyro-
sine kinases Lck and Fyn (Raab et al., 1995) and the
Tec family tyrosine kinases ITK/EMT and Tec (August
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CTLA-4 and CD28 share z30% amino acid homologySummary
within their cytoplasmic domains. Consensus PI(3)K
SH2–domain binding motifs and proline-rich sequencesCD28 and CTLA-4 are related members of a family of
are present within the cytoplasmic domains of both re-T lymphocyte cell surface receptors that function to ceptors. CTLA-4, like CD28, can be phosphorylated by
regulate T cell activation. We have found that the cyto- and can associate with Src kinases (Bradshaw et al.,
plasmic domains of both CTLA-4 and CD28 can asso- 1997; Miyatake et al., 1998; Chuang et al., 1999). How-
ciate with members of the PP2A family of serine/threo- ever, the effects of Src-mediated regulation downstream
nine phosphatases. The association of PP2A with of each receptor appear to be distinct. CD28 phosphory-
CD28 was negatively regulated by tyrosine phosphory- lation by Lck or Fyn results in PI(3)K recruitment and
lation of the CD28 cytoplasmic domain. Inhibition of activation, which may regulate CD28 trafficking (Cefai
PP2A activity in Jurkat leukemia T cells by treatment et al., 1998) or activate the AKT survival pathway (Parry
with okadaic acid or by expression of a dominant- et al., 1997). Phosphorylation of CTLA-4 may instead
inhibit interactions of CTLA-4 with clathrin-associatednegative mutant enhanced T cell activation induced by
adaptor protein complexes, which can regulate CTLA-4CD28 engagement. Interactions between cell surface
cell-surface expression (Thompson and Allison, 1997).receptors such as CTLA-4 and CD28 and serine/threo-
The cytoplasmic domain of CTLA-4 has also been dem-nine phosphatases may represent a novel mechanism
onstrated to associate with PI(3)K (Schneider et al.,for modulating the intracellular signal transduction
1995), SHP-2 (Marengere et al., 1996), and the CD3zpathways associated with cell activation.
chain of the TCR (Lee et al., 1998). However, the mecha-
nisms by which CTLA-4 inhibits T cell activation inducedIntroduction by TCR/CD28 stimulation remain poorly understood.
Reversible protein phosphorylation is a major mecha-
T cell activation is initiated by the binding of peptide- nism for the regulation of intracellular signal transduc-
bound major histocompatibility (MHC) molecules on an- tion pathways. There are four major classes of serine/
tigen-presenting cells (APC) to the T cell receptor (TCR) threonine phosphatases of which the defining members
on T cells. Whether such interactions result in T cell are PP1, PP2A, PP2B, and PP2C. Novel phosphatases
proliferation is, under many conditions, dependent upon having homology to existing members have also been
interactions between costimulatory and inhibitory re- recently identified (Cohen, 1997). Of the serine/threonine
ceptors on T cells with their ligands. CD28 and CTLA-4 phosphatases, PP1 and PP2A are the most closely re-
are structurally homologous receptors on T cells that lated, whereas PP2C is the most divergent. PP2A is
bind to shared ligands B7-1 (CD80) and B7-2 (CD86). an important negative regulator of signal transduction
Whereas binding of its ligands to CD28 results in T cell pathways regulating cell growth and mitogenesis in re-
costimulation, binding of ligands to CTLA-4 results in sponse to extracellular stimuli. In cells, the majority of
inhibition of T cell activation. The molecular basis for PP2A can be found either as a core heterodimer com-
these distinct outcomes is poorly understood, although posed of a catalytic C subunit bound to an invariant A
there is evidence that both CD28 and CTLA-4 can regu- subunit or, more frequently, as a heterotrimer consisting
late TCR-induced signal transduction. Stimulation of the of the core AC heterodimer bound to a variable B regula-
tory subunit. The B subunit is thought to confer substrate
specificity and to regulate enzymatic activity of the holo-k To whom correspondence should be addressed (e-mail: craig@
mail.med.upenn.edu). enzyme, and displacement of the B subunit by viral gene
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products such as SV40 small t antigen can lead to dereg-
ulation of PP2A activity (Sontag et al., 1993). Recently,
PP2A has been found to associate with novel partners
not falling within the classical A or B subunit categories
(reviewed in Goldberg, 1999; Millward et al., 1999; West-
phal et al., 1999). These include the a4 protein, the trans-
lation termination factor eRF1, and several protein ki-
nases.
As a result of a search for intracellular binding partners
for the CTLA-4 receptor, we have found that the cyto-
plasmic domain of CTLA-4, as well as the cytoplasmic
domain of CD28, can associate with members of the
serine/threonine phosphatase family. We suggest that
association of cytoplasmic phosphatases with cell sur-
face receptors may represent a novel mechanism by
which cell surface receptors can regulate intracellular
signal transduction cascades.
Results
To identify proteins that could interact with CTLA-4, we
performed a yeast two-hybrid screen using the cyto-
plasmic domain of CTLA-4 to screen a mouse T cell
leukemia cDNA library. Of 500,000 transformants, 25
were found to be CTLA-4 specific. Eleven of these
Figure 1. The Cytoplasmic Domain of CTLA-4 Interacts with theclones were identified as the catalytic subunit of the Catalytic Subunit of PP2A
serine/threonine phosphatase PP2A and one as PP6, a
(A) The cytoplasmic domain of CTLA-4 interacts with members ofnovel member of the PP2A-like family of serine/threo- a family of serine/threonine phosphatases. The cytoplasmic domain
nine phosphatases (Cohen, 1997). In addition, the PP2A of CTLA-4 was used to screen a cDNA library from a mouse T
B56 regulatory subunit (McCright et al., 1996) and the leukemia cell line, using the yeast two-hybrid system. Of the clones
PP2A-associated protein a4 were also identified as in- found to specifically interact with CTLA-4, 11 encoded the catalytic
teracting with CTLA-4 (Figure 1A). These findings sug- subunit of PP2A. Other proteins related to this family of serine/
threonine phosphatases were also identified. The number of timesgested that the cytoplasmic domain of CTLA-4 could
each protein was independently cloned is indicated in parentheses.interact with related serine/threonine phosphatases and
(B) Interaction of CTLA-4 with the catalytic subunit of PP2A is medi-their associated subunits.
ated by CTLA-4 residues surrounding Y201. Site-directed mutagen-Of the 11 PP2A clones obtained in the yeast two-
esis was performed on the CTLA-4 cytoplasmic domain and thehybrid screen, eight encoded the full-length PP2A cata- effects of mutations on CTLA-4/PP2A interactions assessed. Rela-
lytic subunit (amino acids 1–309). The smallest fragment tive b-galactosidase activity is indicated. The activity resulting from
of PP2A identified in the yeast two-hybrid screen as wild-type CTLA-4/PP2A interactions was assigned an arbitrary
interacting with CTLA-4 encoded PP2A amino acids score of 11.
220–309 (data not shown). To determine which amino
acids within the cytoplasmic domain of CTLA-4 were
necessary for binding to PP2A, site-directed mutagene- bers identified in the yeast two-hybrid screen, gluta-
sis of the CTLA-4 cytoplasmic domain was performed thione S-transferase (GST) or GST fused to the CTLA-4
and interactions with PP2A assessed (Figure 1B). Sub- cytoplasmic domain encoded in triplicate (GST CTLA-43)
stitution of amino acids Y201 and M204 markedly di- was expressed in HEK293 cells and the coprecipitation
minished the association that had been detected with of endogenous PP2A with GST proteins examined. We
the entire CTLA-4 cytoplasmic domain. Substitution have previously demonstrated that GST CTLA-43 exhib-
of alanines for prolines in the proline-rich domain had its sensitive and specific association with other proteins
no effect upon binding. Interestingly, substitution of that bind to CTLA-4 (Chuang et al., 1997; Lee et al.,
V202K203 within the SH2 domain consensus binding 1998). As shown in Figure 2A, GST CTLA-43, but not
motif YVKM in CTLA-4 with the corresponding motif in GST, coprecipitated endogenous PP2A. A GST fusion
CD28 (YMNM) enhanced the association of CTLA-4 with protein containing a single copy of the CTLA-4 cyto-
PP2A. The results of these studies suggested that the plasmic GST CTLA-4 also precipitated PP2A but to a
interaction of CTLA-4 with PP2A involved CTLA-4 resi- lesser extent (data not shown). In the yeast two-hybrid
dues surrounding Y201. Furthermore, the finding that screen, the B56 subunit of PP2A was also found to
minor point mutations within the CTLA-4 cytoplasmic associate with CTLA-4. To examine if the B56 subunit
domain abolished the interaction with PP2A confirmed could also interact with CTLA-4 in HEK293 cells, HA-
that the interaction was mediated by CTLA-4 and not tagged PP2Ac (catalytic subunit) and HA-tagged B56
by the yeast two-hybrid reporter protein. were coexpressed with either GST CTLA-43 or GST and
the presence of HA-tagged proteins in GST precipitates
examined. HA-PP2Ac but not the HA-B56 was found to
Biochemical Association of the CTLA-4 Cytoplasmic specifically coprecipitate with GST CTLA-43. The ab-
Domain with PP2A sence of a detectable association between the trans-
To determine whether CTLA-4 could interact biochemi- fected B56 subunit and CTLA-4 may be due to an inabil-
ity of the B56 subunit to associate with its normalcally with the serine/threonine phosphatase family mem-
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Figure 2. The Cytoplasmic Domain of
CTLA-4 Associates with PP2A in HEK293
Cells
(A) Association with endogenous PP2A.
HEK293 cells were transiently transfected
with expression plasmids encoding either
GST or GST CTLA-43 or a control plasmid
(CD28Dtail). GST proteins were precipitated
and separated by SDS-PAGE. The presence
of endogenous PP2A was detected by West-
ern blotting using a monoclonal anti-PP2A
antibody.
(B) Association with HA-PP2Ac but not HA-
B56. HEK293 cells were transiently trans-
fected with plasmids encoding GST or GST
CTLA-43 together with plasmids encoding the
catalytic (PP2Ac) and B56 subunits of PP2A
tagged with HA at the N terminus. GST pre-
cipitates were prepared from cell lysates and
the coprecipitation of HA-PP2Ac or HA-B56
determined by Western blotting using an anti-
HA antibody (top panels). The blot containing
the GST precipitates was reprobed using an
anti-GST antibody (bottom panel).
partners in HEK293 cells. Whether CTLA-4 associates in transfected HEK293 cells. As shown in Figure 3, al-
though G/c:cCTLA-4 did not coprecipitate PP2A, inser-with B55, the most prevalent B subunit isoform, or
tion of three glycines (G/c:c(gly3)CTLA-4) significantlywhether the association between CTLA-4 and PP2A oc-
enhanced the amount of PP2A coprecipitated. Surpris-curs with a trimolecular (ABC) PP2A holoenzyme was
ingly, the recombinant GST protein containing the fusionnot evaluated in these experiments.
with the cytoplasmic domain of CD28 (G/c:cCD28) was
more effective than the CTLA-4-containing fusion pro-
teins at precipitating endogenous PP2A. Insertion ofThe Cytoplasmic Domain of CD28 Associates
three glycines into G/c:cCD28 (G/c:c(gly3)CD28) or dele-with PP2A
tion of the coiled-coil element (GST CD28) reduced theIt was possible that the reduced ability of GST CTLA-4
amount of PP2A coprecipitated, although significantto coprecipitate PP2A compared with GST CTLA-43 was
quantities could still be detected (Figure 3A). Using puri-due to an obscuring of the interacting site by the much
fied proteins, Flag-tagged PP2Ac was found to directlylarger GST protein or to a conformationally unfavorable
associate with the cytoplasmic domain of CD28 in aposition of the cytoplasmic tail of CTLA-4 in the fusion
concentration-dependent manner but did not associateprotein. Alternatively, the higher order multimerization
with the cytoplasmic domain of the costimulatory recep-of the cytoplasmic domain in the GST CTLA-43 fusion
tor CD40 fused to GST at any of the concentrationsprotein compared with GST CTLA-4 could enhance
tested (Figure 3B). Thus, association with other costimu-binding to PP2A. To investigate some of these possibili-
latory receptors was not a general property of PP2Aties and to confirm the finding from the yeast two-hybrid
interactions but was specific for CD28. Furthermore,system that a single copy of the CTLA-4 cytoplasmic
G/c:cCD28 did not precipitate recombinant PP2B, thedomain could bind to PP2A, we utilized a strategy ini-
serine/threonine kinase MKK4, or the medium chain oftially described for studying integrin/cytoskeletal protein
the clathrin-associated adaptor protein m2 (Figure 3C).interactions. In this strategy, recombinant proteins were
As previously reported, the cytoplasmic domain ofmade by linking the cytoplasmic domains of integrin
CTLA-4 coprecipitated m2. The G/c:cCD28 protein did
subunits to a dimerized coiled-coil structure specified not interact with endogenous PP6 (data not shown) in
by four heptad repeats (Pfaff et al., 1998). Insertion of HEK293 cells, despite our findings using the yeast two-
one to three glycines carboxy-terminal to the coiled- hybrid system that the CTLA-4 cytoplasmic domain
coil imparted different degrees of a-helical turn to the could associate with PP6. The relative differences we
cytoplasmic domain sequences under study. Therefore, have observed between the association of different
we constructed a recombinant protein consisting of GST types of serine/threonine phosphatases with the cyto-
and four heptad repeats connected to a single copy of plasmic domains of either CD28 or CTLA-4 may be due
the CTLA-4 cytoplasmic domain (G/c:cCTLA-4). Three to differences in the systems used to detect the associa-
glycines were inserted C-terminal to the heptad repeats tions; alternatively, they may reflect physiological differ-
so that the conformation of the CTLA-4 cytoplasmic ences in the roles of distinct phosphatases in the regula-
domain could be varied (G/c:c(gly3)CTLA-4). Because tion of CD28 or CTLA-4 signal transduction in vivo. Both
the cytoplasmic domain of CD28 has homology to the cytoplasmic domains of CTLA-4 and CD28 were
CTLA-4 and may share common signal-transducing found to specifically associate with PP2A. Because the
binding partners, a GST coiled-coil fusion with the association of PP2Ac with CD28 was easier to detect
cytoplasmic domain of CD28 was also constructed than with CTLA-4, additional studies aimed at character-
(G/c:cCD28). The ability of these fusion proteins to bind izing the interaction in more detail were directed at CD28
rather than CTLA-4.to endogenous PP2A was determined by coprecipitation
Immunity
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Figure 3. CD28 Associates with PP2A
(A) Both the CTLA-4 and CD28 cytoplasmic
domains can associate with PP2Ac. HEK293
cells were transiently transfected with plas-
mids encoding GST (G), GST CD28 (G/C28),
GST coiled-coil (G/c:c), GST coiled-coil fused
to the CD28 (G/c:cC28) or CTLA-4 (G/c:cC4)
cytoplasmic domains, or GST proteins with
three glycines inserted between the coiled-
coil and the cytoplasmic domain sequences
(G/Gly3c:c, G/Gly3 c:cC4, G/Gly3 c:cC28). Ly-
sates were prepared and normalized for GST
protein concentration. GST proteins were
precipitated and the presence of coprecipi-
tated endogenous PP2A determined by SDS-
PAGE and Western blotting using an anti-
PP2A antibody (top panel). Five percent of
the GST precipitates were analyzed on a sec-
ond gel by Western blotting using an anti-
GST antibody (bottom panel).
(B) PP2A associates with the cytoplasmic do-
main of CD28 but not the cytoplasmic domain
of CD40. E. coli–purified GST fusion proteins
(G/c:c, G/CD40, G/c:cC4, G/c:cC28) were
added at a concentration of 10 mg/ml to a 96-
well plate precoated with glutathione BSA.
Either 1, 5, or 10 ng of baculovirus-purified
Flag-PP2A was added. The amount of PP2A
bound to GST fusion proteins was deter-
mined by ELISA using an anti-Flag HRP an-
tibody.
(C) The cytoplasmic domain of CD28 interacts
specifically with PP2Ac but not with PP2B,
MKK4, or m2. Forty nanograms of purified
G/c:c, G/c:cC28, or G/c:cC4 (without the Gly3
insertion) were incubated with purified re-
combinant PP2B, Flag-tagged MKK4(K111R), Flag-tagged PP2A, or lysates from 293 cells expressing HA-tagged m2. GST precipitates were
prepared and separated by SDS-PAGE. The presence of coprecipitated proteins was determined by Western blotting of membranes, using
the indicated antibodies. The relative quantities of interacting proteins used for each reaction are indicated in the lane marked “standard,”
and a representative Western blot showing the quantity of GST protein precipitated is shown in the bottom panel.
(D) Association of the CD28 receptor with endogenous PP2A in nontransfected cells. Lysates from 5 3 107 Jurkat cells were incubated with
tosyl-activated Dynabeads precoupled with either a rat anti-CD28 antibody or a rat IgG2b isotype control. The presence of CD28 and PP2A
in immunoprecipitates was detected by Western blotting using a polyclonal anti-CD28 (top panel) or a monoclonal anti-PP2A antibody (bottom
panel).
Association of CD28 with PP2A in Jurkat Cells C subunits. As shown in Figure 4A, bands corresponding
to the A, B, and C subunits were found to coprecipitateTo examine if the CD28 receptor formed a complex with
PP2A in nontransfected cells, CD28 was immunoprecipi- with GST/c:cCD28. To examine if CD28 could associate
with the PP2A catalytic subunit alone, GST or GST/tated from Jurkat cell lysates and the presence of en-
dogenous PP2A examined by Western blotting. As c:cCD28 proteins were incubated with PP2A that con-
sisted of the PP2A catalytic subunit without the A or Bshown in Figure 3D, PP2A was found to coimmunopre-
cipitate with CD28. Thus, in vivo, PP2A can be detected subunits (Promega PP2A), with PP2A that contained
the A, B, and C subunits (UBI PP2A), or with purifiedas a component of the CD28 signaling complex.
baculovirus Flag-PP2A. As shown in Figure 4B, GST/
c:cCD28 coprecipitated both the isolated PP2A C sub-CD28 Associates with the PP2A Holoenzyme
unit and the PP2A heterotrimer.and with the PP2Ac Subunit Alone
The majority of PP2A is found as a trimolecular (ABC)
complex. We examined if the PP2Ac that associated
with CD28 existed as part of a PP2A holoenzyme. First, CD28 Association with PP2A Is Negatively
Regulated by LckFlag-PP2Ac was purified from Sf9 insect cells and the
purified protein subjected to gel electrophoresis and Interactions between CD28 and CTLA-4 with intracellu-
lar proteins can be regulated by tyrosine phosphoryla-SYPRO Orange staining. As shown in Figure 4A, Flag-
PP2Ac coassociated with two proteins that migrated tion of the receptor cytoplasmic domains. To determine
whether phosphorylation of CD28 could regulate itswith molecular weights (MW) that approximated the MW
of the PP2A A (65 kDa) and B (55 kDa) subunits. These binding to PP2Ac, purified G/c:cCD28 was mixed in an
in vitro kinase reaction with purified GSTLck and theproteins were identified as the insect regulatory subunits
by tryptic digestion and mass spectrometry (data not effect of CD28 tyrosine phosphorylation on PP2A bind-
ing determined. As shown in Figure 5A, tyrosine phos-shown). To determine if CD28 coprecipitated the hetero-
trimeric PP2A complex, purified GST or GST/c:cCD28 phorylation of CD28 reduced binding of PP2Ac to CD28.
Of note, the majority of Lck-induced CD28 tyrosinewas incubated with purified Flag-PP2Ac. GST precipi-
tates were examined for the presence of the A, B, and phosphorylation occurs on the YMNM motif (Rudd,
Association of CTLA-4 and CD28 Receptors with PP2A
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Figure 4. CD28 Associates with the Heterotrimeric PP2A (ABC) Complex and Also with the Isolated C Subunit
(A) Association of CD28 with baculovirus-purified Flag-PP2A occurs with the trimolecular complex. Purified GST or GST/c:cCD28 (0.3 mg)
were incubated with 0.3 mg of baculovirus-expressed Flag-PP2Ac purified from Sf9 insect cells. GST precipitates were separated on a 4%–20%
polyacrylamide gel and the gel analyzed by SYPRO Orange staining. Lanes to the right of the MW markers (M) labeled 1 and 2 represent GST
and GST/c:cCD28 precipitates, respectively. Samples of purified proteins are shown to the left of the MW marker lane. The two upper bands
present in the lane labeled “Flag-PP2A” were subjected to tryptic digestion and mass spectrometric analysis and identified as the insect A
and B regulatory subunits. The lower band is the recombinant Flag-PP2A C subunit.
(B) Association of CD28 with the isolated PP2A C subunit. Purified GST or GST/c:cCD28 was incubated with the isolated PP2A C subunit
(Promega PP2A), the PP2A heterotrimeric (ABC) complex (UBI PP2A), or with baculovirus-expressed Flag-PP2A. GST was precipitated, and
the presence of the PP2A C subunit in GST precipitates was determined by Western blotting using a monoclonal antibody that recognizes
the PP2A C subunit (top panel). The same blot was reprobed with an anti-GST antibody (bottom panel).
1996), which forms the PI(3)K binding site in CD28 that tautomycin, an inhibitor of PP1 activity. Stimulation of
Jurkat T cells with anti-CD28 in the presence of 50 nMis equivalent to the Y201 residue in CTLA-4.
okadaic acid resulted in a 50% enhancement of IL-2
secretion compared with stimulation in the absence ofCD28-Associated PP2A Is Enzymatically Active
OA or in the presence of lower concentrations of OA (5To determine whether the CD28-associated PP2Ac was
nM). Stimulation of Jurkat T cells in the presence ofenzymatically active, GST precipitates were prepared
the PP1 inhibitor tautomycin had no effect upon CD28-from HEK293 cells expressing G/c:cCD28 or G/c:c and
induced IL-2 production. Although OA is a specific inhib-the presence of associated endogenous PP2A serine/
itor of PP2A at low concentrations (IC50 0.2 nM), atthreonine phosphatase activity determined. As shown
higher concentrations it also may inhibit PP1 (IC50 10in Figure 6, using pSer and pThr peptides as substrates,
nM), and its effect on novel PP2A-like phosphatasesG/c:cCD28 but not G/c:c alone coprecipitated PP2Ac
such as PP6 has not been well characterized. To deter-activity. The level of phosphatase activity precipitated
mine whether the enhancement in CD28-induced IL-2by CD28 was comparable to the activity immunoprecipi-
secretion by OA treatment was a specific effect of inhib-tated by an anti-PP2Ac antibody in the same experi-
iting PP2A activity, a PP2A mutant predicted to be cata-ment. These results demonstrate that the endogenous
lytically inactive was generated by changing the histi-PP2A associated with CD28 is catalytically active.
dine at position 59 (H59) to lysine. H59 is conserved
among the catalytic subunits of PP1, PP2A, and PP2BInhibition of PP2A Activity Enhances CD28-
(Cohen, 1989) and based upon information from theDependent IL-2 Production in Jurkat T Cells
crystal structure of PP1, provides one of the criticalTo determine the effect of inhibiting PP2A phosphatase
catalytic residues by coordinating binding to the requi-activity on CD28-dependent T cell function, Jurkat leu-
site divalent metal ions Mn21 and Fe21 (Barford, 1996).kemia T cells were pretreated with okadaic acid (OA),
Jurkat T cells were transfected with cDNA encoding HA-an inhibitor of PP2A activity, and the effect on CD28-
tagged H59K PP2A (H59K), HA-tagged wild-type PP2Ainduced IL-2 production assessed (Figure 7A). In the
same experiment, some cells were also treated with (wt), or a vector control plasmid (neo). Both transfected
Figure 5. The Association of CD28 with PP2A
Is Negatively Regulated by CD28 Tyrosine
Phosphorylation
One hundred nanograms of GST/c:cCD28 (G/
c:cC28) was incubated with GST Lck (G/Lck)
in an in vitro kinase reaction. The reactions
were diluted 1:25 with binding buffer con-
taining 20 ng of Flag-PP2A (FPP2Ac). GST
precipitates were obtained, and the copre-
cipitation of Flag-PP2A was determined by
Western blotting using an anti-Flag antibody
(A). The membrane was stripped and re-
probed using antibodies to phosphotyrosine
(B) and to GST (C).
Immunity
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Figure 6. The Cytoplasmic Domain of CD28 Coprecipitates Serine/
Threonine Phosphatase Activity
Lysates were prepared from untransfected HEK293 cells (293 mock)
or HEK293 cells transiently transfected with plasmids encoding
GST/c:c, GST/c:cCD28, or GST/c:cCTLA-4. GST precipitates (gluta-
thione Seph), PP2A immunoprecipitates (prot. G/a-PP2Ac), or con-
trol precipitates incubated with protein G agarose alone (prot. G
agarose) were prepared, and the presence of coprecipitated serine/
threonine phosphatase activity was determined by incubation with
a mixture of pSer and pThr peptides. Released phosphate was
Figure 7. CD28-Induced IL-2 Production in Jurkat T Cells Is En-
detected using a colorimetric assay. Shown for comparison are
hanced by Inhibition of PP2A Activity
phosphatase activities of known quantities of recombinant PP2Ac
(A) J32 Jurkat cells were incubated with the indicated concentrationsand PP1cg determined in the same assay (standards).
of either okadaic acid (OA) or tautomycin (taut) and stimulated with
plate-bound anti-CD28 for 20 hr. Supernatants were removed, and
the concentration of IL-2 was determined by ELISA. Error bars are
clones expressed stable levels of HA-tagged proteins present but not visible.
with wild-type PP2A expressed at reproducibly higher (B) J32 Jurkat cells were stably transfected with the pCDNA3 vector
levels than the mutant (data not shown). The effect of (neo), the vector encoding the human PP2A catalytic subunit in
which histidine 59 has been mutated to lysine (H59K) or the wild-CD28 ligation on IL-2 production in these clones was
type PP2A catalytic subunit (wt). Individual subclones expressingassessed. As shown in Figure 7B, clones transfected
the recombinant proteins were stimulated with anti-CD28 for 20with the vector control secreted minimal amounts of
hr. The production of IL-2 was determined by ELISA. Shown areIL-2 in response to anti-CD28 stimulation. Expression
representative results for four neo clones, one wt clone, and fourof transfected wt PP2A did not affect CD28-induced
H59K clones.
IL-2 secretion. In contrast, clones transfected with the
H59K PP2A mutant secreted enhanced amounts of IL-2
in response to CD28 ligation. Thus, inhibition of PP2A
(Penninger and Crabtree, 1999). Although the regulated
activity by OA treatment or by expression of a dominant-
activation of protein kinase cascades during T cell acti-
negative mutant enhanced CD28-induced IL-2 pro-
vation has been intensively studied, the mechanisms by
duction. The lack of an effect of wt PP2A in these
which protein serine/threonine phosphatases partici-
experiments may be due to the abundant amount of
pate in the regulation of these pathways remain unchar-
endogenous PP2A that exists in cells, such that expres-
acterized. It is likely, however, that serine/threonine
sion of recombinant wt PP2A at the levels achieved does
phosphatases also function as important regulators of
not significantly perturb overall PP2A function; alterna-
cellular pathways associated with T cell activation and
tively, it has been reported that the levels of PP2A are
T cell costimulation, as a critical role for these phospha-
under autoregulation and that expression of recombi-
tases in the regulation of cell proliferation, differentia-
nant PP2A reduces the amount of endogenous PP2A,
tion, and survival has been demonstrated in other cell
such that total cellular PP2A levels are not significantly
types.
changed (Baharians and Schonthal, 1998).
In a screen for CTLA-4-interacting proteins, the cyto-
plasmic domain of CTLA-4 was found to associate with a
Discussion family of PP2A-related serine/threonine phosphatases.
The structurally homologous but functionally distinct re-
ceptor CD28 was also found to associate with PP2A.It has been proposed that the outcome of TCR stimula-
tion is dependent upon the organization of antigen re- Through interactions with serine/threonine phospha-
tases, CD28 and CTLA-4 are potentially positioned toceptors, costimulatory receptors, and adhesion mole-
cules on the T cell plasma membrane (Shaw and Dustin, directly regulate protein kinase cascades that are asso-
ciated with T cell activation. Both CD28 and PP2A have1997). Such clustering might function to assemble sig-
naling molecules and to promote sustained signaling been reported to regulate the activation of several pro-
tein kinases, including several members of the MAPKthrough pathways necessary for lymphocyte activation
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family. Studies have demonstrated that CD28 costimula- CD28 by targeting of PP2A activity to CD28. Alterna-
tion acts synergistically with TCR stimulation to activate tively, recruitment of PP2A to the site of TCR-mediated
Jun-N-terminal kinase (JNK), with resultant AP-1 activa- activation could lead to dephosphorylation and inactiva-
tion and IL-2 production (Su, 1994; Barz et al., 1998; tion of the serine/threonine kinase cascades reported
Kempiak et al., 1999). Similarly, inhibition of PP2A activ- to be activated downstream of the receptor.
ity in T cells using the PP2A inhibitor OA has also been In summary, we have found that the cytoplasmic do-
shown to increase IL-2 production (Figure 7A; Richards mains of CTLA-4 and CD28 can associate with members
et al., 1992) and to enhance AP-1 transcription (Nebl et of the serine/threonine phosphatase family, including
al., 1998; Thevenin et al., 1991). Both PP2A and CD28 PP2A and PP6. Together, the data suggest that the inter-
have been reported to regulate the Raf/MEK/ERK path- actions of CTLA-4 and CD28 with serine/threonine phos-
way. TCR-induced ERK activation is transient but can phatases is under complex regulation that may be af-
be prolonged by OA treatment in T cells, suggesting fected by the multimerization and conformation of the
that PP2A functions in the dephosphorylation and down- receptor, tyrosine phosphorylation status, and the pres-
regulation of ERK (Lisbona et al., 1997). Similarly, it was ence of other components of the receptor-associated
shown that stimulation of the TCR resulted in the tran- signaling complex. The association of cell surface re-
sient activation of ERK but that this activation was pro- ceptors with serine/threonine phosphatases represents
longed by costimulation of the CD28 receptor (Calvo et a novel mechanism by which receptors can potentially
al., 1997). Thus, it is possible that CD28 costimulation regulate intracellular signaling cascades that are associ-
functions to prevent the PP2A-mediated dephosphory- ated with T cell activation.
lation of ERK that occurs following TCR stimulation
alone. Experimental Procedures
We found that stimulation of CD28 in the presence of
the PP2A inhibitor OA or a catalytically inactive PP2A Proteins and Antibodies
The mouse mAb Okt3 against human CD3 and the mouse mAbmutant resulted in Jurkat T cell activation and IL-2 pro-
9.3 against human CD28 were generously provided by Dr. C. Juneduction. These findings are consistent with a role for
(University of Pennsylvania, Philadelphia, PA). Anti-hemagglutininPP2A in the negative regulation of CD28 signal transduc-
(12CA5) was purchased from Roche Molecular Biochemicalstion under conditions where TCR signals are not con-
(Roche, Indianapolis, IN), anti-Flag-HRP was purchased from Kodakcomitantly provided. Previous observations have sug-
(Rochester, NY), anti-phosphotyrosine (4G10) from Upstate Biotech-gested that in this setting, CD28 activation is often not
nology (UBI, Lake Placid, NY), anti-GST-HRP from Santa Cruz Bio-
associated with T cell proliferation. However, under technology (Santa Cruz, CA), and monoclonal anti-PP2A and anti-
some conditions, CD28 ligation alone has been reported PP2B from Transduction Labs (Lexington, KY). Goat anti-human
to induce cell activation (Siefken et al., 1998; Woerly CD28 was from R&D Systems. Human PP2B protein was purchased
et al., 1999). Interestingly, in vivo, this effect may be from Calbiochem (San Diego, CA). Purified recombinant GST Lck
(G/Lck) was a generous gift of Dr. Julian Watts (Washington Univer-regulated by CTLA-4, as induction of T cell activation
sity, St. Louis, MO).through CD28 stimulation alone was shown to be en-
hanced in CTLA-4-deficient mice (Mandelbrot et al.,
Plasmids1999). Both CTLA-4 and CD28 can associate with PP2A.
The pAS1 CTLA-4 plasmid was constructed by PCR amplificationPreviously, CD28 and CTLA-4 have been shown to bind
of the cDNA sequence encoding CTLA-4 amino acids 193–223 andPI(3)K when the cytoplasmic tail is tyrosine phosphory-
subcloning into the yeast expression vector pAS1 as previouslylated. If PP2A recruitment is inhibitory for T cell activa-
described (Chuang et al., 1997). Site-directed mutagenesis of thetion and PI(3)K is stimulatory, then the relative affinities
CTLA-4 cytoplasmic domain was performed using the Chameleonand the phosphorylation status of the receptors will de- mutagenesis system (Stratagene, LaJolla, CA), and mutations were
termine whether recruitment of the receptor to the site confirmed by DNA sequencing. The pEBG-(CTLA-4)3plasmid encod-
of TCR engagement will be stimulatory or inhibitory. ing three copies of the CTLA-4 cytoplasmic domain fused to GST
Consistent with this possibility, we have found that the and the plasmid pCDNA3 HA-m2 have been previously described
association between PI(3)K is more readily detectable (Chuang et al., 1997). cDNA inserts from clones that were found to
bind to the CTLA-4 cytoplasmic domain in the yeast two-hybridwith CD28 than with CTLA-4 (Chuang et al., 1999).
screen were subcloned into the XhoI site of a modified pCDNA3Differences in the binding of both CD28 and CTLA-4
vector that encoded a hemagglutinin tag N-terminal to the insertedproteins to PP2A were observed by modifying the struc-
cDNA.ture of the intracellular domains using the coiled-coil
To generate G/c:cCTLA-4, an EcoRI-BglII c:cCTLA-4 gene wasproteins or by modifying tyrosine phosphorylation.
constructed by gene assembly in pT7Blue (Novagen, Madison, WI),Therefore, interactions of the CTLA-4 and CD28 recep- excised with BamHI-BglII, and cloned into the BamHI site of the
tors with ligands that induce distinct changes in protein pEBG plasmid. G/c:cCTLA-4 contains GST followed by the amino
conformation or tyrosine phosphorylation may be ex- acids LVPRGSEQKLISEEDLVPRGSHMCGKLEALEGRLDALEGKLE
pected to differentially regulate the association of ALEGKLDAL (Gly insertions) SK followed by the CTLA-4 intracellular
CTLA-4 or CD28 with PP2A. These differences in binding domain. The NsiI-BglII fragment containing the CTLA-4 domain was
excised from c:cCTLA-4/pT7Blue and replaced with a synthetic NsiI-may explain how association of both CTLA-4 and CD28
BglII fragment encoding the CD28 intracellular domain. The resultingwith PP2A could mediate distinct effects in T cell activa-
BamHI-BglII c:cCD28 was then subcloned into pEBG to generatetion. The specific intracellular pathways that are regu-
G/c:cCD28. The GSTc:c control protein was generated by MatchMakerlated by PP2A as a result of its association with CD28
(Promega, Madison, WI) site-directed mutagenesis to add a stopor CTLA-4 are not known. One possibility is that PP2A
codon following the coiled-coil domain in the plasmid G/c:cCTLA-4.dephosphorylates CD28 itself, as it has been demon- Glycine insertions were added at the junction of the coiled-
strated that cross-linking of CD28 plus treatment of cells coil domain and at the start of the intracellular domain using site-
with the phorbol ester PMA induces the phosphorylation directed mutagenesis. GST CD28 (G/CD28) was generated by sub-
of CD28 on threonine residues (Hutchcroft et al., 1996). cloning the CD28 intracellular domain into BamHI-digested pEBG.
In this setting, the role of CTLA-4 may be to prevent the To generate GST CD40, the human CD40 cytoplasmic tail (aa 232–
291) was subcloned as a BamHI/EcoRI fragment into pGEX-2TKactivation-induced serine/threonine phosphorylation of
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(Amersham Pharmacia, Piscataway, NJ). The protein was evaluated lysate samples using anti-GST-HRP. Lysate samples were then nor-
malized for GST expression by dilution with parental HEK293 cellfor function in the ability to bind TRAF2 and TRAF3.
Human PP2Ac cDNA was amplified from human lymphocyte cDNA lysate. GST was precipitated from lysate samples by addition of
GS4B and incubation for either 1 hr or overnight at 48C. Precipitates(Clontech, Palo Alto, CA) by RT-PCR and inserted into the 59 HindIII-39
EcoRI sites of the mammalian expression plasmid pHM6 (Roche) were separated by SDS-polyacrylamide electrophoresis, transferred
onto nitrocellulose membranes, and probed with the indicated anti-for mammalian expression with an N-terminal hemagglutinin (HA)
epitope tag. The H59K mutation was generated by site-directed bodies. Results were visualized using enhanced chemilumines-
cence (Amersham Pharmacia) or SuperSignal West Pico Substratemutagenesis. The human PP2Ac was reamplified to add a 59 BamHI
site for subcloning into 59 BamHI-39 EcoRI of pFastBac1 (Life Tech- system (Pierce, Rockford, IL) and analyzed by Lumi-Imager image
capture (Roche).nologies, Grand Island, NY) modified with an N-terminal Flag epitope
tag for baculoviral expression. Similarly, human MKK4 cDNA was
amplified by PCR and subcloned into pFastBac1/N-Flag using 59 CD28 Immunoprecipitations
BamHI-39 SpeI. Jurkat cells (5 3 107) were lysed in buffer containing 25 mM Tris (pH
7.6), 0.5% Triton X-100, 100 mM NaCl, 1 mM MgCl, 2 mM DTT, 0.1%
Protein Purification BSA, and Complete protease inhibitor tablets (Roche). Lysates were
Recombinant GST and GST/coiled-coil proteins were expressed by precleared with control IgG-coated beads and immunoprecipitated
IPTG induction of E. coli grown in 23 YT media and purified by a with 40 ml of antibody-coated Tosyl-activated Dynabeads M-280 at
sarkosyl lysis method (Frangioni and Neel, 1993), using single-step 6 3 108 beads/ml (Dynal, Lake Success, NY) overnight at 48C. Beads
affinity purification over glutathione Sepharose 4B (GS4B) affinity were coated with rat anti-human CD28 antibody YTH 913.12 (Sero-
resin (Amersham Pharmacia). Baculovirus-expressed Flag-MKK4 tec, Raleigh, NC) or rat IgG2b isotype control antibody (PharMingen)
and Flag-PP2Ac were purified by single-step affinity purification at 1 mg/ml in 0.1 M Na-phosphate buffer (pH 7.4) according to
using M2 anti-Flag affinity resin (Sigma, St. Louis, MO) and eluted manufacturer’s instructions. Immunoprecipitations were washed
from the column using 250 mg/ml Flag peptide diluted in column and collected by magnetic separation. Western blotting for PP2A
wash buffer. Protein concentrations were determined by Bradford was performed as above, and results were obtained using SuperSig-
Assay (Bio-Rad, Hercules, CA) and by in-gel quantitation using nal West Pico Substrate System and Lumi-Imager image capture.
SYPRO Orange protein stain (Bio-Rad).
Phosphatase Assays
Yeast Two-Hybrid Screen GST precipitates or PP2A immunoprecipitates were prepared from
Yeast two-hybrid screening was performed using pAS1 CTLA-4 as HEK293 cells transiently transfected with plasmids encoding GST
bait to screen a mouse T cell leukemia cDNA library cloned into the proteins. Seventy-five microliters of a reaction mix containing 200
pACT yeast expression plasmid, using the Matchmaker 2-hybrid mM each pSer and pThr peptides (UBI) was added to the samples
system protocol (Clontech) as previously described (Gedrich et al., and mixed intermittently at 308C for 30 min. Beads were pelleted,
1996). A result was scored positive if both growth in the absence and 25 ml of each reaction was mixed with 100 ml malachite green
of histidine occurred and b-galactosidase activity was observed. solution to detect released phosphate. Samples were read at 750
nM using a Molecular Devices 96-well plate reader.
Cell Lines and Transfections
For stable transfections, plasmids were introduced by electropora- PP2A ELISAs
tion of 20 mg of DNA, using the Bio-Rad Gene Pulser set at 250 V GST fusion proteins were added at a concentration of 10 mg/ml
and 960 mF, into the human T cell leukemia cell line J32 Jurkat to a 96-well plate that had been precoated with glutathione-BSA.
(Makni et al., 1991). Transfectants were selected by growth in 0.3 Purified recombinant Flag-PP2Ac protein (1, 5, or 10 ng) was added,
mg/ml of G418 (Life Technologies). Single-cell subclones were ob- and the plate was incubated for 2 hr at room temperature. A 1:10,000
tained by limiting dilution and protein expression determined by dilution of an M2-anti-Flag HRP antibody was added, followed by
Western blotting of cell lysates using an anti-HA antibody. Transient addition of the substrate solution. The peroxidase reaction was
transfections of the cell line HEK293 were performed using standard stopped with 0.18 M H2SO4, and the plate was read at 450 nM using
calcium phosphate methods or using the FuGene 6 system (Roche) a Molecular Dynamics plate reader. The concentration of plate-
according to the manufacturer’s instructions. Cell lines were main- bound GST fusion proteins present in control wells in which PP2A
tained in either RPMI (Jurkat) or DMEM (HEK293) media supple- had not been added was determined using an anti-GST HRP anti-
mented with 10% FCS, 2–4 mM glutamine, 50 mM HEPES (pH 7.5), body. Flag-PP2A detection data were normalized to the concentra-
100 U/ml penicillin, and 100 mg/ml streptomycin. Jurkat cells used tion of plate-bound GST protein thus determined.
for immunoprecipitations were from ATCC.
For Jurkat cell stimulations, 2 3 105 cells were grown in 96-well
CD28 Kinase Reactions
plates that were coated with 10 mg/ml of goat anti-mouse IgG (Kir-
One hundred nanograms GST proteins were incubated with or with-
kegaard and Perry Laboratories, Gaithesburg, MD) plus 1 mg/ml of
out GST Lck in kinase reaction buffer (50 mM Hepes [pH 7.55], 24
the mouse anti-human CD28 antibody 9.3 where indicated. In some
mM MgCl2, 125 mM NaCl, 100 mM ATP, and 100 mM NaVO3) for 1wells, okadaic acid (Roche) or tautomycin (Calbiochem) was added.
hr at 308C and diluted to 500 ml with cold binding buffer (25 mM
Cells were grown for 18 to 20 hr, and supernatants were removed.
Tris [pH 8], 150 mM NaCl, 0.1% NP40, 2.5 mg/ml BSA, 1 mM NaVO3,IL-2 was measured by ELISA using the antibody pair 5344.111 and
1 mM MgCl2, and 0.1 mM MnCl2) containing 40 ng/ml Flag-PP2Ac.B33-2 (PharMingen, San Diego, CA) according to the manufacturer’s
protocol.
Identification of PP2A Regulatory Subunits
Protein bands were excised from SDS-PAGE gels and trypticallyGST Precipitations and Western Blotting
digested. The tryptic peptides were separated using reverse-phaseFor experiments using purified GST proteins, E. coli–produced GST
HPLC and sequenced using tandem mass spectrometry. Sequenceproteins were incubated at a ratio of 1:1 with purified PP2B, Flag-
analysis was performed using the SEQUEST algorithm.MKK4, or Flag-PP2Ac in binding buffer (1% NP40, 20 mM Tris [pH
8], 150 mM NaCl, 1 mM MgCl2, 0.1 mM MnCl2, and 1 mg/ml BSA)
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